Zwick et al, Trends in Molecular Medicine (2002) 8: 17-23
ANTISENS OLIGONUCLEOTIDE AS RECEPTOR TYROSINE KINASE -BASED
 DRUGS IN CLINICAL TRIALS
2003-2004